» Articles » PMID: 32471191

Comparison Between Diffusion-Weighted Sequences with Selective and Non-Selective Fat Suppression in the Evaluation of Crohn's Disease Activity: Are They Equally Useful?

Overview
Specialty Radiology
Date 2020 May 31
PMID 32471191
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

: We compared the efficiency of two MRI diffusion weighted imaging (DWI) techniques: DWI with SPIR (DWI) and DWI with STIR (DWI), to estimate their eligibility for quantitative assessment of Crohn's disease activity in children and adults. : In inflamed terminal ileum segments ( = 32 in adults, = 46 in children), Magnetic Resonance Index of Activity (MaRIA) was calculated, ADC values of both DWI techniques were measured, and the corresponding Clermont scores calculated. ADC values of both DWI techniques were compared between both and within each patient group, assessing their mutual correlation. Correlations between MaRIA and the corresponding ADC values, and Clermont scores based on both DWI techniques were estimated. : No correlation between ADC of DWI and DWI was observed (rho = 0.27, = 0.13 in adults, rho = 0.20, = 0.17 in children). The correlation between MaRIA and Clermont scores was strong in both techniques-in SPIR, rho = 0.93; < 0.0005 in adults, rho = 0.98, < 0.0005 in children, and, in STIR, rho = 0.89; < 0.0005 in adults, rho = 0.95, < 0.0005 in children. The correlation between ADC and MaRIA was moderate negative for DWI (rho = 0.93, < 0.0005 in adults, rho = 0.95, < 0.0005 in children), but, in DWI, no correlation between ADC and MaRIA score was observed in adults (rho = -0.001, = 0.99), whereas children presented low negative correlation (rho = -0.374, = 0.01). : DWI is not suitable for quantitative assessment of Crohn's disease activity both in children and adult patients.

Citing Articles

Role of abbreviated non-contrast-enhanced MR-enterography in the evaluation of Crohn's disease activity and complications as an alternative for full protocol contrast-enhanced study: A systematic review and meta-analysis.

Jannatdoust P, Valizadeh P, Razaghi M, Rouzbahani M, Abbasi A, Arian A Res Diagn Interv Imaging. 2024; 6:100030.

PMID: 39077544 PMC: 11265495. DOI: 10.1016/j.redii.2023.100030.

References
1.
Dohan A, Taylor S, Hoeffel C, Barret M, Allez M, Dautry R . Diffusion-weighted MRI in Crohn's disease: Current status and recommendations. J Magn Reson Imaging. 2016; 44(6):1381-1396. DOI: 10.1002/jmri.25325. View

2.
Buisson A, Joubert A, Montoriol P, Da Ines D, Ines D, Hordonneau C . Diffusion-weighted magnetic resonance imaging for detecting and assessing ileal inflammation in Crohn's disease. Aliment Pharmacol Ther. 2013; 37(5):537-45. DOI: 10.1111/apt.12201. View

3.
Ordas I, Rimola J, Alfaro I, Rodriguez S, Castro-Poceiro J, Ramirez-Morros A . Development and Validation of a Simplified Magnetic Resonance Index of Activity for Crohn's Disease. Gastroenterology. 2019; 157(2):432-439.e1. DOI: 10.1053/j.gastro.2019.03.051. View

4.
Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M . Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Radiat Med. 2004; 22(4):275-82. View

5.
Gulani V, Calamante F, Shellock F, Kanal E, Reeder S . Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 2017; 16(7):564-570. DOI: 10.1016/S1474-4422(17)30158-8. View